Yearly Archives: 2014

About one-third of type 1 diabetics (T1D) produce insulin even upward of forty years from initial diagnosis, according to a new study.

The American Diabetes Association is recommending a less stringent diastolic blood pressure target for people with diabetes and that all people with diabetes take either moderate or high doses of statins.

Type 1 diabetics who have developed low blood sugar (hypoglycemia) as a complication of insulin treatments over time are able to regain normal internal recognition of the condition after receiving pancreatic islet cell transplantation.

The ADA is lowering the Body Mass Index (BMI) cut point at which it recommends screening Asian Americans for type 2 diabetes.

The most popular treatment for type 2 diabetes may be safer for patients with mild to moderate kidney disease than guidelines suggest, according to a new review.

According to a new long-term study, diabetic patients with even mild coronary artery disease face the same relative risk for a heart attack or other major adverse heart events as diabetics with serious single-vessel obstructive disease.

Researchers were able to show a correlation between patients treated with a higher dosage of insulin and a raised risk of cancer development, heart attacks and stroke.

According to a major new study, routine heart imaging screenings for people with diabetes at high risk to experience a cardiac event, but who have no symptoms of heart disease, does not help them avoid heart attacks, hospitalization for unstable angina or cardiac death.

Men who have low testosterone and Type 2 diabetes face a greater risk of developing atherosclerosis - a condition where plaque builds up in the arteries - than men who have diabetes and normal testosterone levels.

A research team has developed a drug delivered through a skin patch that not only helps foot wounds heal better, but also prevents those wounds from recurring

Exposure to moderate amounts of sunshine may slow the development of obesity and diabetes, a study suggests.

Scientists have discovered a new class of molecules—produced in human and mouse fat—that protects against diabetes.

Researchers announced that they have made a giant leap forward in the quest to find a truly effective treatment for type 1 diabetes.

Scientists have created a drug for type 2 diabetes that is switched on by blue light, which they hope will improve treatment of the disease.

For people living with type 1 diabetes, also known as juvenile diabetes, there is a big development to get excited about. Watch this news...

https://www.youtube.com/watch?v=qaq1aBLMOCk